AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32306797 — intervention group
Group type: COMPARATOR
Intervention: DAPT: aspirin+prasugrel/ticagrelor
Number of subjects: 130
Study 34354017 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain neuroscience education (PNE) training
Number of subjects: 319
Study 34354017 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 319
Study 34478926 — intervention group
Group type: EXPERIMENTAL
Intervention: Atosiban (6.75 mg IV 30 min before embryo transfer, followed by 18 mg/h for 1 h, then 6 mg/h for 2 h)
Number of subjects: 50
Study 34478926 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline solution)
Number of subjects: 50
Study 34478926 — intervention group
Group type: EXPERIMENTAL
Intervention: Atosiban
Number of subjects: 50
Study 34478926 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 34478926 — intervention group
Group type: EXPERIMENTAL
Intervention: Atosiban (in women >35 years)
Number of subjects: 50
Study 34478926 — intervention group
Group type: COMPARATOR
Intervention: Placebo (in women >35 years)
Number of subjects: 50
Study 35085999 — intervention group
Group type: EXPERIMENTAL
Intervention: Real dry needling (DN)
Number of subjects: 50
Study 35085999 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling
Number of subjects: 50
Study 33938088 — intervention group
Group type: EXPERIMENTAL
Intervention: PFO closure plus antiplatelet therapy
Number of subjects: 145
Study 33938088 — intervention group
Group type: COMPARATOR
Intervention: Antiplatelet therapy alone
Number of subjects: 145
Study 32870042 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous Protein Solution (APS) injection
Number of subjects: 46
Study 32870042 — intervention group
Group type: COMPARATOR
Intervention: Saline injection
Number of subjects: 46
Study 36040742 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (minimum of 3 supervised 90-minute sessions per week for 20 weeks)
Number of subjects: 109
Study 36040742 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 109
Study 33184453 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine status (measured as urinary iodine concentration - UIC)
Number of subjects: 954
Study 33184453 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine status (UI/Cr <150 µg/g)
Number of subjects: 954
Study 34478596 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation-based training (in situ simulation training)
Number of subjects: 0
Study 34478596 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulation experience
Number of subjects: 0
Study 32088370 — intervention group
Group type: EXPERIMENTAL
Intervention: Hematopoietic stem cell transplantation (HSCT) in GATA2 cohort
Number of subjects: 0
Study 32088370 — intervention group
Group type: COMPARATOR
Intervention: Control A (patients without germline GATA2 mutations and BMF/MDS)
Number of subjects: 0
Study 32088370 — intervention group
Group type: COMPARATOR
Intervention: Control B (patients without germline GATA2 mutations and acute leukemia)
Number of subjects: 0
Study 34152238 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth management with an implantable glucose sensor and a mobile application
Number of subjects: 68
Study 34152238 — intervention group
Group type: COMPARATOR
Intervention: Usual health management
Number of subjects: 68
Study 33582258 — intervention group
Group type: EXPERIMENTAL
Intervention: Laryngeal Tube (LT)
Number of subjects: 1996
Study 33582258 — intervention group
Group type: COMPARATOR
Intervention: Endotracheal Intubation (ETI)
Number of subjects: 1996
Study 35551053 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) using a low-level GaAlAs diode laser (continuous wave of 810 nm wavelength, power of 200 mW, energy density of 12–14 J/cm2) for 12 sessions (2 times/week for 6 weeks)
Number of subjects: 26
Study 35551053 — intervention group
Group type: COMPARATOR
Intervention: Control group (laser probe turned off)
Number of subjects: 26
Study 35551053 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT)
Number of subjects: 26
Study 33637567 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured education programme (n=145)
Number of subjects: 291
Study 33637567 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n=146)
Number of subjects: 291
Study 32343625 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 30
Study 32343625 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 33214537 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based weight loss intervention
Number of subjects: 194
Study 33214537 — intervention group
Group type: COMPARATOR
Intervention: Active-control with identical diet-exercise guidelines
Number of subjects: 194
Study 32022725 — intervention group
Group type: EXPERIMENTAL
Intervention: CPPopt (optimal cerebral perfusion)
Number of subjects: 0
Study 32022725 — intervention group
Group type: EXPERIMENTAL
Intervention: ABPopt (arterial pressures)
Number of subjects: 0
Study 32022725 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood pressure regulation above the lower limit of autoregulation
Number of subjects: 0
Study 32022725 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted control of brain and systemic blood pressures
Number of subjects: 0
Study 33641621 — intervention group
Group type: EXPERIMENTAL
Intervention: Protect Your Family intervention administered by lay healthcare workers
Number of subjects: 1399
Study 33641621 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 1399
Study 32939989 — intervention group
Group type: EXPERIMENTAL
Intervention: EIP/GBR
Number of subjects: 38
Study 32939989 — intervention group
Group type: COMPARATOR
Intervention: ARP/CTG
Number of subjects: 38
Study 32380509 — intervention group
Group type: EXPERIMENTAL
Intervention: Acid-suppressive therapy + feeding bundle
Number of subjects: 76
Study 32380509 — intervention group
Group type: COMPARATOR
Intervention: Acid-suppressive therapy only (conventional)
Number of subjects: 76
Study 32291466 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity (BMI ≥ 30 kg/m2)
Number of subjects: 4729
Study 32291466 — intervention group
Group type: EXPERIMENTAL
Intervention: High genetic risk (GRS quintile 5)
Number of subjects: 4729
Study 32291466 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfavourable lifestyle
Number of subjects: 4729
Study 32291466 — intervention group
Group type: EXPERIMENTAL
Intervention: Low GRS and favourable lifestyle with obesity
Number of subjects: 4729
Study 35443618 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional Neural Network (CNN) algorithm using lateral cervical spine radiographs
Number of subjects: 207
Study 32525410 — intervention group
Group type: EXPERIMENTAL
Intervention: OCT-guided BVS implantation
Number of subjects: 176
Study 32525410 — intervention group
Group type: COMPARATOR
Intervention: Angiography-guided BVS implantation
Number of subjects: 176
Study 32525410 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 176
Study 36179986 — intervention group
Group type: EXPERIMENTAL
Intervention: Omidubicel
Number of subjects: 108
Study 36179986 — intervention group
Group type: COMPARATOR
Intervention: Standard UCB
Number of subjects: 108
Study 33064895 — intervention group
Group type: EXPERIMENTAL
Intervention: New metformin users with depression
Number of subjects: 165056
Study 33064895 — intervention group
Group type: COMPARATOR
Intervention: New metformin users without depression (controls)
Number of subjects: 165056
Study 33064895 — intervention group
Group type: EXPERIMENTAL
Intervention: Trajectories of adherence
Number of subjects: 165056
Study 32971492 — intervention group
Group type: EXPERIMENTAL
Intervention: Isokinetic eccentric training protocols at 45°/s, 120°/s, 210°/s, and 300°/s
Number of subjects: 47
Study 32971492 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 14)
Number of subjects: 47
Study 37732853 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 49
Study 37732853 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 49
Study 35732505 — intervention group
Group type: EXPERIMENTAL
Intervention: True Acupuncture (TA) group, 20 sessions over 8 weeks, each session lasting 30 minutes, achieving deqi sensation.
Number of subjects: 218
Study 35732505 — intervention group
Group type: COMPARATOR
Intervention: Superficial Acupuncture (SA) group, same sessions and treatment frequency as TA, avoiding deqi sensation.
Number of subjects: 218
Study 33268427 — intervention group
Group type: EXPERIMENTAL
Intervention: Logistic regression with various missing data imputation methods
Number of subjects: 355823
Study 33268427 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest
Number of subjects: 355823
Study 33268427 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural networks
Number of subjects: 355823
Study 33268427 — intervention group
Group type: EXPERIMENTAL
Intervention: Case-wise deletion for missing data
Number of subjects: 355823
Study 33268427 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean value imputation, random forest, extremely randomised trees (extra-trees regression), ridge regression, normal value imputation
Number of subjects: 355823
Study 36195963 — intervention group
Group type: EXPERIMENTAL
Intervention: MyComrade intervention
Number of subjects: 121
Study 33127571 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular coiling (specific type not mentioned, but includes bare platinum coils and hydrogel coils)
Number of subjects: 270
Study 33127571 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular coiling (specific type not mentioned)
Number of subjects: 270
Study 33127571 — intervention group
Group type: COMPARATOR
Intervention: Literature review on QOL in patients with UIAs
Number of subjects: 270
Study 36418118 — intervention group
Group type: EXPERIMENTAL
Intervention: Financial incentive of €20
Number of subjects: 10000
Study 36418118 — intervention group
Group type: COMPARATOR
Intervention: Mailing back the HPV self-sampling kit (HPVss)
Number of subjects: 10000
Study 34559691 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentle, massage-like head stroking for 60 minutes
Number of subjects: 14
Study 34559691 — intervention group
Group type: COMPARATOR
Intervention: Control group (resting without massage)
Number of subjects: 14
Study 36442467 — intervention group
Group type: EXPERIMENTAL
Intervention: Early feeding group (1 day of trophic feeding at 20-24 mL/kg/day)
Number of subjects: 60
Study 36442467 — intervention group
Group type: COMPARATOR
Intervention: Late feeding group (4 days of trophic feeding at 20-24 mL/kg/day)
Number of subjects: 60
Study 33632144 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (part of the BREATHE trial)
Number of subjects: 410
Study 35966238 — intervention group
Group type: EXPERIMENTAL
Intervention: Childlike concept with refined nursing intervention
Number of subjects: 100
Study 35966238 — intervention group
Group type: COMPARATOR
Intervention: Refined nursing care
Number of subjects: 100
Study 33526496 — intervention group
Group type: EXPERIMENTAL
Intervention: Describing side effects as a sign treatment is working
Number of subjects: 0
Study 33526496 — intervention group
Group type: COMPARATOR
Intervention: Standard empathetic message about side effects
Number of subjects: 0
Study 35315017 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (nifedipine, nicardipine)
Number of subjects: 65
Study 35315017 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy pregnant women, n=65)
Number of subjects: 65
Study 32147352 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum PSA-based screening
Number of subjects: 4276
Study 32147352 — intervention group
Group type: COMPARATOR
Intervention: Follow-up without intervention
Number of subjects: 4276
Study 34476447 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oral health education after treatments
Number of subjects: 60
Study 34476447 — intervention group
Group type: COMPARATOR
Intervention: Clinical education at the time of treatments
Number of subjects: 60
Study 32044268 — intervention group
Group type: EXPERIMENTAL
Intervention: Microwave Ablation (MWA)
Number of subjects: 93
Study 32044268 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency Ablation (RFA)
Number of subjects: 93
Study 35468646 — intervention group
Group type: EXPERIMENTAL
Intervention: Endo-TLIF
Number of subjects: 46
Study 35468646 — intervention group
Group type: COMPARATOR
Intervention: Open-TLIF
Number of subjects: 46
Study 34604400 — intervention group
Group type: EXPERIMENTAL
Intervention: Spiritual counseling (8 sessions of 60 minutes each)
Number of subjects: 50
Study 33312712 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT), low-energy intervention group, treated once a week for 10 weeks.
Number of subjects: 40
Study 33312712 — intervention group
Group type: COMPARATOR
Intervention: Placebo control group, treated once a week for 10 weeks.
Number of subjects: 40
Study 35906106 — intervention group
Group type: EXPERIMENTAL
Intervention: PVRV‐NG
Number of subjects: 342
Study 35906106 — intervention group
Group type: COMPARATOR
Intervention: HDCV
Number of subjects: 342
Study 32752306 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermotherapy plus neck stabilization exercise
Number of subjects: 35
Study 32752306 — intervention group
Group type: COMPARATOR
Intervention: Neck stabilization exercise alone
Number of subjects: 35
Study 36244813 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence group (near-infrared autofluorescence and indocyanine green fluorescence)
Number of subjects: 0
Study 36244813 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorescence group
Number of subjects: 0
Study 34411059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative dexmedetomidine use
Number of subjects: 562
Study 34411059 — intervention group
Group type: EXPERIMENTAL
Intervention: Frontal location of tumor
Number of subjects: 562
Study 34411059 — intervention group
Group type: COMPARATOR
Intervention: Awake craniotomy
Number of subjects: 562
Study 32340878 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer simulation group (using data from duplex ultrasonography for model simulations)
Number of subjects: 236
Study 32340878 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard work up without simulation)
Number of subjects: 236
Study 32340878 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate post-operative flow prediction
Number of subjects: 236
Study 36115774 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual segmentation
Number of subjects: 391
Study 36115774 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated segmentation
Number of subjects: 391
Study 36115774 — intervention group
Group type: COMPARATOR
Intervention: Radiologist assessment
Number of subjects: 391
Study 36115774 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined model of manually segmented radiomics signature and radiologist assessment
Number of subjects: 391
Study 34886168 — intervention group
Group type: EXPERIMENTAL
Intervention: CR + IMT
Number of subjects: 90
Study 34886168 — intervention group
Group type: COMPARATOR
Intervention: CR
Number of subjects: 90
Study 34886168 — intervention group
Group type: COMPARATOR
Intervention: IMT
Number of subjects: 90
Study 32690105 — intervention group
Group type: EXPERIMENTAL
Intervention: NEON Intervention (treatment as usual plus immediate access to the NEON Intervention for 1 year)
Number of subjects: 883
Study 32690105 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis using EQ‐5D‐5 L and Client Service Receipt Inventory data
Number of subjects: 883
Study 32690105 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual plus access to the NEON Intervention after 1 year
Number of subjects: 883
Study 35985418 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month home-based physical exercise (supervised by physiotherapist, 60 minutes, twice a week)
Number of subjects: 299
Study 35985418 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month home-based physical exercise
Number of subjects: 299
Study 35985418 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 299
Study 34938893 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral magnesium oxide (MgOx)
Number of subjects: 15
Study 34938893 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral magnesium citrate (MgCit)
Number of subjects: 15
Study 36443737 — intervention group
Group type: EXPERIMENTAL
Intervention: TURNing InTervention (TURN‐IT)
Number of subjects: 60
Study 36443737 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 60
Study 34128480 — intervention group
Group type: EXPERIMENTAL
Intervention: Endo.Adm feedback
Number of subjects: 16
Study 34128480 — intervention group
Group type: COMPARATOR
Intervention: No feedback (control group)
Number of subjects: 16
Study 35181385 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label placebo (OLP) nasal spray
Number of subjects: 84
Study 35181385 — intervention group
Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 84
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: PCV13 (13-valent pneumococcal conjugate vaccines)
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphtheria toxoid and tetanus toxoid vaccine
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: 23-valent pneumococcal polysaccharide vaccine (PPSV23)
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Flaxseed extract
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethinyl estradiol
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric extract
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Ubidecarenone
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Azelastine
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudoephedrine
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextromethorphan
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone
Number of subjects: 9748
Study 34314511 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 9748
Study 32759229 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplement
Number of subjects: 60
Study 32759229 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 32302791 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Number of subjects: 300
Study 32302791 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness meditation (MM)
Number of subjects: 300
Study 32302791 — intervention group
Group type: EXPERIMENTAL
Intervention: Activation skills (AS)
Number of subjects: 300
Study 32302791 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 300
Study 33499887 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone 40 mg days 1 to 4, then 20 mg days 5 to 8
Number of subjects: 184
Study 33499887 — intervention group
Group type: COMPARATOR
Intervention: Usual care defined by the attending physician
Number of subjects: 184
Study 33499887 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone treatment
Number of subjects: 184
Study 32971040 — intervention group
Group type: EXPERIMENTAL
Intervention: semaglutide 0.5 mg
Number of subjects: 8416
Study 32971040 — intervention group
Group type: EXPERIMENTAL
Intervention: semaglutide 1.0 mg
Number of subjects: 8416
Study 35711417 — intervention group
Group type: EXPERIMENTAL
Intervention: High-risk group (based on prognostic model of eight PCD-related lncRNAs)
Number of subjects: 0
Study 35711417 — intervention group
Group type: COMPARATOR
Intervention: Low-risk group (based on prognostic model of eight PCD-related lncRNAs)
Number of subjects: 0
Study 35711417 — intervention group
Group type: COMPARATOR
Intervention: Cluster 2 (identified through cluster analysis)
Number of subjects: 0
Study 35711417 — intervention group
Group type: EXPERIMENTAL
Intervention: lncRNA U62317.4 (studied in vitro and in vivo)
Number of subjects: 0
Study 34174448 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 101
Study 34174448 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 101
Study 32891139 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly vitamin D2 50,000 IU
Number of subjects: 96
Study 32891139 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly vitamin D2 2500 IU
Number of subjects: 96
Study 32891139 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study 36335344 — intervention group
Group type: EXPERIMENTAL
Intervention: Misoprostol provided by midwives
Number of subjects: 1140
Study 36335344 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol provided by physicians
Number of subjects: 1140
Study 32816890 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib (5 mg twice daily) and Pembrolizumab (2 mg/kg every 3 weeks)
Number of subjects: 52
Study 32816890 — intervention group
Group type: EXPERIMENTAL
Intervention: Axitinib and Pembrolizumab
Number of subjects: 52
Study 36225761 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie monitoring (Standard)
Number of subjects: 72
Study 36225761 — intervention group
Group type: EXPERIMENTAL
Intervention: Red food monitoring (Simplified)
Number of subjects: 72
Study 36225761 — intervention group
Group type: COMPARATOR
Intervention: Both interventions
Number of subjects: 72
Study 35140341 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative radiotherapy
Number of subjects: 1178
Study 35140341 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic gene signatures
Number of subjects: 1178
Study 34758759 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychomotor intervention program (EG1)
Number of subjects: 51
Study 34758759 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined exercise program (psychomotor intervention + whole-body vibration program) (EG2)
Number of subjects: 51